GOODACRE, Simon Charles,LABADIE, Sharada,LIANG, Jun,ORTWINE, Daniel Fred,RAY, Nicholas Charles,WANG, Xiaojing,ZBIEG, Jason,ZHANG, Birong
申请号：
HK18102605.3
公开号：
HK1243074A
申请日:
2018.02.23
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure: and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
